Literatur
- 1
Boysen G.
Bleeding complications in secondary stroke prevention by antiplatelet therapy: a benefit-risk
analysis.
J Intern Med.
1999;
246
239-245
- 2
Cole A T, Hudson N, Liew L C, Murray F E, Hawkey C J, Heptinstall S.
Protection of human gastric mucosa against aspirin-enteric coating or dose reduction?.
Aliment Pharmacol Ther.
1999;
13
187-193
- 3
Dammann H G, Burkhardt F, Wolf N.
Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions.
Aliment Pharmacol Ther.
1999;
13
1109-1114
- 4
Johnson E S, Lanes S F, Wentworth C E, Satterfield M H, Abebe B L, Dicker L W.
A metaregression analysis of the dose-response effect of aspirin on stroke.
Arch Intern Med.
1999;
159
1248-1253
- 5
Kusche W, Paxinos R, Haselmann J, Schwantes U, Breddin H K.
Acetylsalicylic acid tablets with glycine improve long-term tolerability in antiplatelet
drug therapy: results of a noninterventional trial.
Adv Ther.
2003;
20
237-245
- 6
Lip G, Felmeden D.
Antiplatelet agents and anticoagulants for hypertension.
Cochrane Database Syst Rev.
2004;
3
CD003186
- 7
Muller P, Dammann H G, Bergdolt H, Simon B.
The effect of glycine on the gastroduodenal tolerability of acetylsalicylic acid.
An endoscopic, controlled double-blind study in healthy subjects.
Arzneimittelforschung.
1991;
41
812-814
- 8
Stalnikowicz-Darvasi R.
Gastrointestinal bleeding during low-dose aspirin administration for prevention of
arterial occlusive events. A critical analysis.
J Clin Gastroenterol.
1995;
21
13-16
- 9
Taubert D, Berkels R, Schömig R.
Acetylsalicylsäure - ein geeignetes Mittel zur Krebsprävention?.
Dtsch Med Wochenschr.
2004;
129
439-442
Dr. Ulf Maywald
Institut für Klinische Pharmakologie, Medizinische Fakultät der TU Dresden
Fiedlerstraße 27
01307 Dresden
Phone: 0351/4585196
Fax: 0351/4584341
Email: ulf.maywald@mailbox.tu-dresden.de
